PeptideDB

Thalidomide-O-amido-PEG3-C2-NH2

CAS No.: 1957236-20-2

Thalidomide-O-amido-PEG3-C2-NH2 (Cereblon Ligand-Linker Conjugates 3) is an E3 ligase ligand-linker conjugate which is d
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Description Thalidomide-O-amido-PEG3-C2-NH2 (Cereblon Ligand-Linker Conjugates 3) is an E3 ligase ligand-linker conjugate which is designed using Thalidomide-based cereblon ligand and a 3-unit PEG linker. This compound is synthesized specifically for utilization in PROTAC technology.
In vitro Thalidomide-O-amido-PEG3-C2-NH2 (Cereblon Ligand-Linker Conjugates 3) is composed of Degron (E3 ubiquitin ligase) and a linker, and they are used in PROTAC technology. Thalidomide-O-amido-PEG3-C2-NH2 binds to the targeting ligand to induce the target protein (including BRD4, BRD2, and BRD3) degradation[1].
Synonyms Cereblon Ligand-Linker Conjugates 3, E3 Ligase Ligand-Linker Conjugates 14
molecular weight 506.51
Molecular formula C23H30N4O9
CAS 1957236-20-2
Storage Powder: -20°C for 3 years | In solvent: -80°C for 1 year
References 1. Methods to induce targeted protein degradation through bifunctional molecules. WO 2017007612 A1